Due Diligence
Who guards the Guards in life science companies?
This isn’t a new question; it’s been asked by every civilisation, from the Greeks on holding people in power to account, and the Romans...
Swiss Biotech Day 2018: Themes, trends and thoughts
Last week I attended the Swiss BioTech Annual Meeting and their 20th Anniversary. The life sciences industry is facing a fascinating new era, and...
Efficient engagement with executive search
When looking for a new role, you’ll have plenty of questions for a potential new employer. Ahead of any interview, you’ll do your due...
New talent needed for a new era of market access in the medtech industry
The last decade has seen the unprecedented growth of innovative and improved medical technologies. In turn, this has led to the development of a...
Engaging with executive interims – time for a fresh perspective
Habits are hard to break and all too often we return to established patterns of behaviour rather than looking for innovative ways to do...
Diversity: A call to arms for Biotech Leaders and Investors
A panel discussion, led by The RSA Group, at the recent BIA UK CEO & Investor Forum discussed the demographic time bomb facing biotech boards...
The value of engaging Pharmacoeconomic executive interims
So what is Pharmacoeconomics? Pharmacoeconomics, is the “scientific discipline which evaluates the clinical, economic and humanistic aspects of pharmaceutical products, services, and programmes, as...
Hiring international executives and the (true) costs of failure
A tale of two …points of view? “It was the best of times, it was the worst of times, it was the age of...
Interim leaders are not ‘temps’ – choose wisely and reap the rewards
We’re all familiar with the concept – there’s an absence at work and we need some cover. A quick Google search and we send...
LEAP HR Life Sciences: HR with Impact and Agile Biotechs
Last week RSA attended LEAP HR: Life Sciences in Boston, Massachusetts. From past experience we were expecting a high value event and we were not disappointed....
Ipsen choose RSA Group as strategic partner for executive talent acquisition in Europe
We have been selected by Ipsen, one of the world’s leading innovators in patient care, as their chosen strategic partner in Europe for executive...
Avoid firing through better hiring
Luke Johnson, the serial entrepreneur and investor made a critical insight in his recent column in the Sunday Times. He wrote about how difficult and costly it...
Due diligence needed in exec hiring: the difference between success and failure
We recently showed the cost of making bad senior hires, with 48% going wrong in the first 18 months. To remind you of the enormity of...
Hiring new talent – it pays to be diligent
Companies hire new senior talent to fuel corporate success. Too often it proves to be an expensive failure. New data from Leadership IQ1 across...
Lowering the business risk of hiring senior talent
Hiring the wrong people into senior positions is a big financial and reputational risk. Recent research shows that 48% of new hires fail within...